Fred Hutch, NIH experts outlined plan for COVID-19 vaccines
On May 11, 2020, in a perspective published by the journal Science, Dr. Larry Corey from the Fred…
NIH clinical trial testing antiviral remdesivir plus antiiInflammatory drug baricitinib for COVID-19 began
On May 8, 2020, the NIH announced that a randomized, controlled clinical trial evaluating the safety and efficacy…
NIH-supported research examines impact of COVID-19 on rare diseases community
On May 7, 2020, the NIH announced a new online survey launched by the NIH-supported Rare Diseases Clinical…
Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On May 6, 2020, Predictive Oncology announced the acquisition of Soluble Therapeutics and partnership and licensing of a…
Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…
NIH study to determine incidence of novel Coronavirus infection in US children began
On May 4, 2020, a NIH study to help determine the rate of novel coronavirus infection in children…
AbCellera identified antibodies for potential use in drugs to treat and prevent COVID-19
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
Biotechnology | COVID-19 | NIH | Therapeutics
NIH’s axing of bat coronavirus grant a ‘horrible precedent’ and might break rules, critics say
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
Emory University launched study on COVID-19 immune responses
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
NIH mobilized national innovation initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new $1.5 billion federal stimulus funding initiative aimed to speed…
NIH clinical trial shows remdesivir accelerated recovery from advanced COVID-19
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
NIH mobilized national innovation RADx initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new initiative aimed at speeding innovation, development and commercialization of…
Expert U.S. panel developed NIH treatment guidelines for COVID-19
On Apr. 21, 2020, a panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…
RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
CDC | COVID-19 | Life Science History | NIH
The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
COVID-19 | NIH | Therapeutics
Antiviral remdesivir prevented disease progression in monkeys with COVID-19
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
OHSU received more than $11 million to continue brain, cognitive development research
On Apr. 17, 2020, the National Institutes of Health (NIH) announced nearly $290 million of new funding for…
COVID-19 | Infectious Disease | NIH | Vaccine
IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
Landmark study of adolescent brain development renewed for additional seven years
On Apr. 15, 2020, the National Institutes of Health renewed its commitment to the Adolescent Brain Cognitive Development…
Biotechnology | Diagnostics | Neurology | NIH
NIH BRAIN Initiative tool helps researchers watch neural activity in 3D
On Apr. 13, 2020, an ultra-fast, 3D imaging technique called SCAPE microscopy, developed through the National Institutes of…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
Autoimmunity may be rising in the United States
On Apr. 8, 2020, NIH scientists and collaborators report that autoimmunity, a condition in which the bodyﾒs immune…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
NIH researchers discovered gene for rare disease of excess bone tissue growth
On Mar. 31, 2020, NIH researchers announced they had discovered a second gene that causes melorheostosis, a rare…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
Biotechnology | COVID-19 | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Therapeutics
National Library of Medicine expanded access to coronavirus literature through PubMed Central
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
NIH shifted non-mission-critical laboratory operations to minimal maintenance phase
On Mar. 20, 2020, to further reduce the risk of transmission of COVID-19 and enhance the safety of…